Metrics as of 10/15/2026, 06:07 AM (Berlin time), refresh in progress.
Siegfried Holding AG
Siegfried Holding AG is a healthcare company headquartered in Zofingen, Switzerland. Founded in 1873, the company engages in contract development and manufacturing of active pharmaceutical ingredients (API) and finished dosage forms worldwide. Its business model includes several segments, such as drug substances which…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
1D
+1.8%
1W
+0.9%
1M
-4.9%
6M
-16.6%
YTD
-6.7%
1Y
-11.9%
2Y
-39.8%
5Y
-20.3%
10Y
+228.0%
Next earnings date
19/02/2027 (in 125 days)
Volatility around earnings
~50% stronger price swings than usual
P/E
17.8
P/B
3.07
EV/EBITDA
12.35
RETURN ON EQUITY
6.8%
NET MARGIN
10.8%
DEBT/EQUITY
0.93
DIVIDEND YIELD
0.6%
AS OF
30/06/2026
FREE FLOAT
91.1%
FLOAT SHARES
39,901,761
AVG. DAILY VOLUME (30D)
108,042
Siegfried Holding AG is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in Switzerland.
The CEO is Marcel Imwinkelried, the company employs around 4,454 people.
The IPO was on 03/04/1995; the stock trades on SIX under the ticker SFZN.SW.
The next earnings date is 19/02/2027.
Around past earnings, price swings were roughly 50% stronger than usual.
Yes. The last dividend was CHF 0.40 per share, ex-date 28/04/2026, paid on 30/04/2026.
The dividend yield is 0.6% (as of 30/06/2026).
Comparable stocks include Sandoz Group, Merck, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Zoetis, Viatris, Lantheus Holdings and Amneal Pharmaceuticals.
Clicking "Analyze stock" lets five strategies assess Siegfried Holding against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.